BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 10398142)

  • 1. Keratinocyte apoptosis and p53 expression in cutaneous lupus and dermatomyositis.
    Pablos JL; Santiago B; Galindo M; Carreira PE; Ballestin C; Gomez-Reino JJ
    J Pathol; 1999 May; 188(1):63-8. PubMed ID: 10398142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Premature keratinocyte death and expression of marker proteins of apoptosis in human skin after UVB exposure.
    Mass P; Hoffmann K; Gambichler T; Altmeyer P; Mannherz HG
    Arch Dermatol Res; 2003 Jun; 295(2):71-9. PubMed ID: 12756586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Keratinocyte and lymphocyte apoptosis: relation to disease outcome in systemic lupus erythematosus patients with and without cutaneous manifestations.
    Salem SA; Farouk HM; Mostafa AA; Hassan IM; Osman WM; Al-Shamy HA; Assaf NY
    Eur J Dermatol; 2010; 20(1):35-41. PubMed ID: 19919906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Matrix metalloproteinases as mediators of tissue injury in different forms of cutaneous lupus erythematosus.
    Järvinen TM; Kanninen P; Jeskanen L; Koskenmies S; Panelius J; Hasan T; Ranki A; Saarialho-Kere U
    Br J Dermatol; 2007 Nov; 157(5):970-80. PubMed ID: 17854363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of p53 and apoptosis in discoid lupus erythematosus.
    Zamolo G; Coklo M; Santini Dusevic D; Kastelan M; Batinac T; Materljan E; Brumini G
    Croat Med J; 2005 Aug; 46(4):678-84. PubMed ID: 16100773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is disturbed clearance of apoptotic keratinocytes responsible for UVB-induced inflammatory skin lesions in systemic lupus erythematosus?
    Reefman E; de Jong MC; Kuiper H; Jonkman MF; Limburg PC; Kallenberg CG; Bijl M
    Arthritis Res Ther; 2006; 8(6):R156. PubMed ID: 17014704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bilharzial related, organ confined, muscle invasive bladder cancer: prognostic value of apoptosis markers, proliferation markers, p53, E-cadherin, epidermal growth factor receptor and c-erbB-2.
    Haitel A; Posch B; El-Baz M; Mokhtar AA; Susani M; Ghoneim MA; Marberger M
    J Urol; 2001 May; 165(5):1481-7. PubMed ID: 11342901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of apoptotic cells and immunohistochemical detection of FAS, FAS-L, Bcl-2, Bax, p53 and c-Myc in the skin of patients with chronic venous leg ulcers.
    Heising S; Giebel J; Ostrowitzki AL; Riedel F; Haase H; Sippel K; Jünger M
    Int J Mol Med; 2008 Oct; 22(4):497-505. PubMed ID: 18813857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of Bcl-2 family proteins in psoriasis.
    Batinac T; Zamolo G; Hadzisejdić I; Zauhar G; Brumini G; Ruzić A; Persić V
    Croat Med J; 2007 Jun; 48(3):319-26. PubMed ID: 17589974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resistance of senescent keratinocytes to UV-induced apoptosis.
    Gniadecki R; Hansen M; Wulf HC
    Cell Mol Biol (Noisy-le-grand); 2000 Feb; 46(1):121-7. PubMed ID: 10726978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apoptosis, PCNA and p53 in hepatocellular carcinoma.
    Paiva C; Oshima CT; Lanzoni VP; Forones NM
    Hepatogastroenterology; 2002; 49(46):1058-61. PubMed ID: 12143201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of apoptosis regulatory proteins p53 and Bcl-2 in skin of patients with chronic renal failure on maintenance haemodialysis.
    El-Domyati MM; Ahmad HM; Nagy I; Zahran A
    J Eur Acad Dermatol Venereol; 2007 Jul; 21(6):795-801. PubMed ID: 17567310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proliferative activity and apoptosis in thymic epithelial neoplasms.
    Hiroshima K; Iyoda A; Toyozaki T; Supriatna Y; Shibuya K; Shimamura F; Haga Y; Yoshida S; Fujisawa T; Ohwada H
    Mod Pathol; 2002 Dec; 15(12):1326-32. PubMed ID: 12481014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical study of apoptosis-related Bcl-2 protein and its correlation with proliferation indices (Ki67, PCNA), tumor suppressor genes (p53, pRb), the oncogene c-erbB-2, sex steroid hormone receptors and other clinicopathological features, in normal, hyperplastic and neoplastic endometrium.
    Mitselou A; Ioachim E; Kitsou E; Vougiouklakis T; Zagorianakou N; Makrydimas G; Stefanaki S; Agnantis NJ
    In Vivo; 2003; 17(5):469-77. PubMed ID: 14598611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of granzyme B-expressing CD-8-positive T cells in lymphocytic inflammatory infiltrate in cutaneous lupus erythematosus and in dermatomyositis.
    Grassi M; Capello F; Bertolino L; Seia Z; Pippione M
    Clin Exp Dermatol; 2009 Dec; 34(8):910-4. PubMed ID: 19456762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of p53 protein and the apoptotic regulatory molecules Bcl-2, Bcl-XL, and Bax in locally advanced squamous cell carcinoma of the lung.
    Shabnam MS; Srinivasan R; Wali A; Majumdar S; Joshi K; Behera D
    Lung Cancer; 2004 Aug; 45(2):181-8. PubMed ID: 15246189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apoptotic signal molecules in skin biopsies of cutaneous lupus erythematosus: analysis using tissue microarray.
    Toberer F; Sykora J; Göttel D; Hartschuh W; Werchau S; Enk A; Joos S; Krammer PH; Kuhn A
    Exp Dermatol; 2013 Oct; 22(10):656-9. PubMed ID: 24079735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apoptosis, P53 and Bcl-2 expression in response to topical calcipotriol therapy for psoriasis.
    El-Domyati M; Barakat M; Abdel-Razek R; El-Din Anbar T
    Int J Dermatol; 2007 May; 46(5):468-74. PubMed ID: 17472673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dermatomyositis: comparative studies of cutaneous photosensitivity in lupus erythematosus and normal subjects.
    Dourmishev L; Meffert H; Piazena H
    Photodermatol Photoimmunol Photomed; 2004 Oct; 20(5):230-4. PubMed ID: 15379871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical expression of Bcl-2 protein in breast lesions: correlation with Bax, p53, Rb, C-erbB-2, EGFR and proliferation indices.
    Ioachim EE; Malamou-Mitsi V; Kamina SA; Goussia AC; Agnantis NJ
    Anticancer Res; 2000; 20(6B):4221-5. PubMed ID: 11205251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.